Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea

Main Article Content

Neal Bhatia
Edward Lain
Hilary Baldwin
Sam Brantman
James Del Rosso
Raja Sivamani






1. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris
[published correction appears in J Am Acad Dermatol. 2020;82(6):1576]. J Am Acad Dermatol.
2016;74(5):945-973. [Table V pg. 951; p. 951 col1, p3; p951 col2p2.]

2. Brammann C, Müller-Goymann CC. Int J Pharm. 2020;578:119074. [pg2, col 2, para3; pg 7 Table 1; pg 9
col 1 para 1; pg 9 col 2 para 4; pg 6 col 1 para 5; pg 6 col 2 para 5]

3. Kolli S, Pecone D, Pona A, et al. Topical retinoids in acne vulgaris: a systematic review. Am J Clin
Dermatol 2019;20(3):345-365. [pg 345 Abstract; pg 346 col 1, para 1; pg 362, col 2 para2; pg 362 col 1
para 3- col 2 para 1]

4. Oztürkcan S, Ermertcan AT, Sahin MT, Afşar FS. Efficiency of benzoyl peroxide-erythromycin gel in
comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol. 2004 Aug;31(8):610-7.
doi: 10.1111/j.1346-8138.

5. Erlich M, Arie T, Koifman N, et al. Structure elucidation of silica-based core-shell microencapsulated
drugs for topical applications by cryogenic scanning electron microscopy. J Colloid Interface Sci. 2020
Nov 1;579:778-785. doi: 10.1016/j.jcis.2020.06.114.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>